Uncovering the Impact of Lymphadenectomy in Advanced Gastric Cancer: A Comprehensive Review.
Venera-Cristina DinescuVeronica GheormanEugen Florin GeorgescuȘtefan PaiticiMarius BicăStefan PatrascuMarius Gabriel BunescuRomeo PopaMihaela Corina BerceanuAna Maria PătrașcuLavinia Maria GheormanSorin Nicolae DinescuIon UdriștoiuVictor GheormanMircea-Catalin FortofoiuTiberiu-Ștefăniță Țenea CojanPublished in: Life (Basel, Switzerland) (2023)
Gastric cancer is a significant health concern worldwide, and lymphadenectomy plays a crucial role in its treatment. However, there is ongoing debate regarding the optimal approach-D1 or D2 lymphadenectomy. This paper aims to synthesize the available evidence by conducting a comprehensive literature review and comparing the advantages and disadvantages of both techniques. The analysis includes studies, clinical trials, and systematic reviews that assess survival outcomes, morbidity, and quality of life. The selected studies revealed different outcomes associated with D1 and D2 lymphadenectomy, including lymph node harvest, disease control, recurrence rates, and overall survival. Postoperative complications also varied between the two techniques. These findings highlight the complex considerations involved in selecting the most suitable lymphadenectomy approach for individual patients. Therefore, the decision requires an individualized assessment that considers the potential benefits and risks of D1 and D2 techniques. A collaborative approach involving interdisciplinary teams is crucial for developing personalized treatment plans that optimize both oncological outcomes and postoperative quality of life.
Keyphrases
- lymph node
- sentinel lymph node
- early stage
- lymph node metastasis
- robot assisted
- neoadjuvant chemotherapy
- clinical trial
- end stage renal disease
- newly diagnosed
- public health
- systematic review
- ejection fraction
- chronic kidney disease
- human health
- squamous cell carcinoma
- case report
- randomized controlled trial
- single cell
- prognostic factors
- rectal cancer
- risk assessment
- radiation therapy
- free survival
- climate change
- combination therapy
- health information
- open label
- study protocol
- glycemic control
- clinical evaluation